Investor FAQs

Show All
When was Myriad Genetics Founded?

Myriad Genetics was founded in May 1991.

Where are your corporate headquarters?

Our corporate headquarters and all our facilities are located at 320 Wakara Way, Salt Lake City, Utah

When did Myriad Genetics become a public company?

We completed our initial public offering in October 1995.

What is Myriad Genetics' CUSIP number?

Our CUSIP number is 62855J104.

What is your stock symbol?

Our common stock is listed on the Nasdaq Global Select Market under the symbol "MYGN."

How can I buy Myriad Genetics stock?

You may purchase our stock through a registered stock broker, bank or through a financial institution that provides brokerage services. Myriad Genetics does not offer a direct purchase plan for investors.

What is the fiscal year for Myriad Genetics?

Our fiscal year ends on June 30.

When do Myriad Genetics' fiscal quarters end?

First quarter – September 30 Second quarter – December 31 Third quarter – March 31 Fourth quarter – June 30

Who is Myriad Genetics' transfer agent?

Our transfer agent is American Stock Transfer & Trust Company. They are responsible for maintaining all records of registered shareholders (including change of address and name), cancelling or issuing stock certificates and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name, you will have to contact your broker for these services. You may contact our transfer agent at:

American Stock Transfer & Trust Company 59 Maiden Lane New York, New York 10038 (800) 937-5449 (718) 921-8124 www.amstock.com

Who should I contact for information about my shareholder account?

If you have questions about your shareholder account you should contact our transfer agent, American Stock Transfer & Trust Company at (800) 937-5499.

How do I contact Myriad Genetics' investor relations department?

Please contact Scott Gleason, Investor Relations, at: 801-584-1143

sgleason@myriad.com